290 related articles for article (PubMed ID: 12654450)
1. Experimental thermoradiotherapy in malignant hepatocellular carcinoma.
Hehr T; Budach W; Lamprecht U; Belka C; Classen J; Trübenbach J; Wehrmann M; Dietz K; Bamberg M
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1374-80. PubMed ID: 12654450
[TBL] [Abstract][Full Text] [Related]
2. A moderate elevation of blood glucose level increases the effectiveness of thermoradiotherapy in a rat tumor model II. Improved tumor control at clinically achievable temperatures.
van den Berg AP; van den Berg-Blok AE; Kal HB; Reinhold HS
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):793-801. PubMed ID: 11395249
[TBL] [Abstract][Full Text] [Related]
3. Thermoradiotherapy for locally recurrent breast cancer with skin involvement.
Hehr T; Lamprecht U; Glocker S; Classen J; Paulsen F; Budach W; Bamberg M
Int J Hyperthermia; 2001; 17(4):291-301. PubMed ID: 11471981
[TBL] [Abstract][Full Text] [Related]
4. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters.
Rau B; Wust P; Tilly W; Gellermann J; Harder C; Riess H; Budach V; Felix R; Schlag PM
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):381-91. PubMed ID: 10974451
[TBL] [Abstract][Full Text] [Related]
5. Whole-body hyperthermia combined with hyperfractionated irradiation of the thorax in dog: acute physiological response.
McChesney Gillette S; Dawson CA; Scott RJ; Rickaby DA; Powers BE; Johnston MR; Chen C; Gillette EL
Int J Hyperthermia; 1993; 9(3):369-82. PubMed ID: 8515140
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency capacitive hyperthermia for deep-seated tumors. II. Effects of thermoradiotherapy.
Hiraoka M; Jo S; Akuta K; Nishimura Y; Takahashi M; Abe M
Cancer; 1987 Jul; 60(1):128-35. PubMed ID: 3581027
[TBL] [Abstract][Full Text] [Related]
7. Quantifying the combined effect of radiation therapy and hyperthermia in terms of equivalent dose distributions.
Kok HP; Crezee J; Franken NA; Stalpers LJ; Barendsen GW; Bel A
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):739-45. PubMed ID: 24411189
[TBL] [Abstract][Full Text] [Related]
8. Elimination of dose-rate effects by mild hyperthermia.
Wang Z; Armour EP; Corry PM; Martinez A
Int J Radiat Oncol Biol Phys; 1992; 24(5):965-73. PubMed ID: 1447038
[TBL] [Abstract][Full Text] [Related]
9. Relationship between thermal parameters and tumor response in hyperthermia combined with radiation therapy.
Xia T; Sun Q; Shi X; Fan N; Hiraoka M
Int J Clin Oncol; 2001 Jun; 6(3):138-42. PubMed ID: 11706783
[TBL] [Abstract][Full Text] [Related]
10. Clinical thermoradiotherapy: the influence of some prognostic parameters on recurrence-free survival.
Lesnicar H
Neoplasma; 1997; 44(1):19-24. PubMed ID: 9201276
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with interstitial hyperthermia and interstitial radiotherapy in an animal tumor model.
Ruifrok AC; Levendag PC; Lakeman RF; Deurloo IK; Visser AG
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1281-6. PubMed ID: 2045302
[TBL] [Abstract][Full Text] [Related]
12. Basic principles in hyperthermic tumor therapy.
Dietzel F
Recent Results Cancer Res; 1983; 86():177-90. PubMed ID: 6647999
[TBL] [Abstract][Full Text] [Related]
13. Changes in tumor oxygenation during a combined treatment with fractionated irradiation and hyperthermia: an experimental study.
Zywietz F; Reeker W; Kochs E
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):155-62. PubMed ID: 9054891
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermia combined with radiation therapy for primarily unresectable and recurrent colorectal cancer.
Nishimura Y; Hiraoka M; Akuta K; Jo S; Nagata Y; Masunaga S; Takahashi M; Abe M
Int J Radiat Oncol Biol Phys; 1992; 23(4):759-68. PubMed ID: 1618669
[TBL] [Abstract][Full Text] [Related]
15. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
Kozin SV; Kozina LV
Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermic enhancement of high dose-rate irradiation in 9L gliosarcoma cells.
Armour EP; Wang Z; Corry PM; Chen PY; Martinez A
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):171-7. PubMed ID: 8270439
[TBL] [Abstract][Full Text] [Related]
17. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group.
Emami B; Scott C; Perez CA; Asbell S; Swift P; Grigsby P; Montesano A; Rubin P; Curran W; Delrowe J; Arastu H; Fu K; Moros E
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1097-104. PubMed ID: 8600093
[TBL] [Abstract][Full Text] [Related]
18. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Horsman MR
Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy and ferromagnetic hyperthermia in the treatment of murine transgenic retinoblastoma.
Murray TG; O'Brien JM; Steeves RA; Smith BJ; Albert DM; Cicciarelli N; Markoe AM; Tompkins DT; Windle JJ
Arch Ophthalmol; 1996 Nov; 114(11):1376-81. PubMed ID: 8906028
[TBL] [Abstract][Full Text] [Related]
20. Interstitial hyperthermia and high dose rate brachytherapy in the treatment of anal cancer: a phase I/II study.
Kapp KS; Kapp DS; Stuecklschweiger G; Berger A; Geyer E
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):189-99. PubMed ID: 8270441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
